Welcome to our dedicated page for Air Prods & Chems SEC filings (Ticker: APD), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
The Air Products & Chemicals, Inc. (NYSE: APD) SEC filings page on Stock Titan provides access to the company’s regulatory disclosures as filed with the U.S. Securities and Exchange Commission. These documents give detailed insight into Air Products’ industrial gases operations, clean hydrogen and low‑emission projects, governance structure and financial reporting.
Through this page, users can review core filings such as annual reports on Form 10‑K and quarterly reports on Form 10‑Q, which describe the company’s industrial gas manufacturing activities, segment performance, risk factors and discussion of results. Current reports on Form 8‑K document material events, including earnings announcements, Board and executive changes, financing transactions and other significant corporate developments. For example, recent 8‑K filings have covered quarterly and full‑year earnings releases and changes in the Board of Directors and senior leadership.
Definitive proxy statements on Schedule 14A provide information on Air Products’ corporate governance, director elections, executive compensation programs and items to be voted on at the annual meeting of shareholders. These materials also include letters from the Board and management describing the company’s strategic focus on its core industrial gases business and its approach to energy transition projects.
On Stock Titan, APD filings are updated in near real time as they are posted to the SEC’s EDGAR system. AI‑powered summaries help explain lengthy documents by highlighting key topics such as segment trends, major projects, capital allocation priorities and governance changes. Users can quickly locate Forms 10‑K and 10‑Q for detailed financial information, Form 8‑K for recent events, and proxy materials for insights into Board composition and executive pay, while AI‑generated overviews make complex disclosures more accessible.
Wayne Thomas Smith, a director of Air Products & Chemicals, Inc. (APD), acquired 22.5421 phantom deferred stock units under the Company’s Deferred Compensation Program for Directors on 09/30/2025. The instrument is described as "Phantom Stock" with a listed conversion/exercise price of $0.0000 and a referenced price of $270.48 in the filing. The filing states these Units are payable in shares equal to the number of Units when paid, generally after the reporting person leaves board service, and may be distributed in a lump sum or up to ten installments as previously elected. After this transaction the reporting person is shown as beneficially owning 3,428.7929 shares (direct).
Dennis H. Reilley, a director of Air Products & Chemicals, Inc. (APD), acquired 7.5709 phantom deferred stock units on 09/30/2025 under the companys Deferred Compensation Program for Directors. These units convert one-for-one into common shares when paid, typically after service on the board ends, and may be delivered as a lump sum or in up to ten installments as elected by the recipient.
Following the reported acquisition the filing shows 1,151.5778 shares beneficially owned by Mr. Reilley on a direct basis. The filing lists an attributable unit value of $270.48 for the phantom stock units but does not disclose cash consideration exchanged for this grant.
Air Products & Chemicals, Inc. director Bhavesh V. Patel acquired 124.734 phantom deferred stock units on 09/30/2025 under the Companys Deferred Compensation Program for Directors. The filing states these Units are part of the Long-Term Incentive Plan and later convert to an equal number of common shares when paid, generally after the directors board service ends; payment can be a lump sum or up to ten installments as elected in advance. The transaction was reported on a Form 4 filed by one reporting person and signed by an attorney-in-fact on 10/02/2025.
Jessica Graziano, a director of Air Products & Chemicals, Inc. (APD), reported a Section 16 transaction dated 09/30/2025. The filing shows acquisition of 156.6796 phantom deferred stock units under the company’s Deferred Compensation Program for Directors, granted under the Long-Term Incentive Plan. The units are payable in shares of common stock equal to the number of units, at a time elected by the reporting person, typically after board service ends, and may be paid in a lump sum or up to ten installments.
The filing lists a reference price of $270.48 and reports 2,183.889 shares beneficially owned following the transaction. The form is signed by an attorney-in-fact on behalf of the reporting person.
Andrew W. Evans, a director of Air Products & Chemicals, Inc. (APD), reported a Section 16 transaction dated 09/30/2025 in which he acquired 3.2558 phantom deferred stock units under the company’s Director Deferred Compensation/Long-Term Incentive plan. The filing shows these units are payable in shares of common stock equal to the number of units at a time elected by the reporting person, generally after Board service ends, and may be paid as a lump sum or in up to ten installments. The report lists a per-share-related figure of $270.48 and indicates the reporting person beneficially owned 495.2362 shares following the transaction, held directly.
Tonit M. Calaway, a director of Air Products & Chemicals, Inc. (APD), reported a transaction dated 09/30/2025 on Form 4 showing acquisition of Phantom deferred stock units under the company’s Deferred Compensation Program for Directors. The filing records an accrual of 15.2704 Units (listed as payable in common stock equal in number to the Units) with a listed value of $270.48 and shows 2,322.728 derivative securities beneficially owned following the transaction. The Units are payable in shares after board service ends and may be taken as a lump sum or up to ten installments as elected by the reporting person.
Howard I. Ungerleider, a director of Air Products & Chemicals, Inc. (APD), reported on Form 4 that on 09/01/2025 he acquired 226.5493 phantom deferred stock units under the company’s director Deferred Compensation Program. The units are convertible into an equal number of common shares and are payable after board service ends, either as a lump sum or in up to ten installments as previously elected. The report shows a reference price of $294.27 and lists 226.5493 shares beneficially owned following the transaction, held directly. The filing was signed on 09/02/2025 by Andrea I. Rennig as attorney-in-fact.
Matthew Lepore, EVP & General Counsel of Air Products & Chemicals, Inc. (APD), reported an acquisition of 3,471 shares of the company's common stock on 08/18/2025. The Form 4 shows the transaction coded as an acquisition with a price listed as $0.0000, and states 3,471 shares are beneficially owned following the reported transaction, held directly. The filing is signed by Andrea I. Rennig as attorney-in-fact on 08/20/2025. No derivative securities or additional transactions are reported and the form does not include further context such as the reason for the $0.0000 price (e.g., grant, gift, or correction) or any change in reporting status.
On 08/18/2025 Matthew Lepore, identified as EVP & General Counsel of Air Products & Chemicals, Inc. (APD), filed an initial Form 3 reporting his relationship to the issuer. The filing states no securities are beneficially owned by the reporting person. The form was signed by Andrea I. Rennig as Attorney in Fact on 08/20/2025.
Air Products & Chemicals, Inc. reported the election of Mr. Ungerleider as a director and noted his compensation will follow the company’s standard non-employee director arrangements described in the definitive proxy statement for the 2025 annual meeting of shareholders. The company states there are no arrangements or understandings between Mr. Ungerleider and any other person related to his election and that neither he nor immediate family members are parties to transactions that would require reporting under Item 404(a) of Regulation S-K. The notice references a press release dated August 20, 2025 and the filing includes an interactive data cover page embedded in the Inline XBRL document. The report is signed by Matthew Lepore, Executive Vice President, General Counsel and Secretary.